Bitcoin Generation Inc. (BTGN)

[gabbyco]

Employees
STEMTIDE™ management are mature, experienced, proven, successful professionals with over 100 years cumulative experience and expertise.

Executive Team

Jay D. Lussan, CEO & Chairman

Mr. Lussan is CEO of STEMTIDE , Inc. A former Partner of Arthur Andersen LLP, he has been active in providing Intellectual Property Start-up and Turnaround Management professional services for nearly forty years, serving as CEO of companies with more than 1,000 employees, three of which have gone public under his direction.





Dana Flavin-König M.D., Chief Science Officer

Dr. Dana F. Flavin-Koenig has studied medicine and science internationally for the past 30 years. Her extensive background in Chemistry, Biochemistry, Pharmacology, Nutrient Biochemistry and Medicine has allowed her to find new ways of enhancing patients’ responses to all treatments. Many new treatments were designed specifically for patients who had little improvement from classical pharmacological agents.

Many of her support measures are nutrients and diets that allow patients to remain in remission and live normal symptom-free lives.

Dr. Flavin-Koenig began her extensive research on the Molecular Biology of Cancer in 1979 when she was appointed Science Assistant to the Associate Bureau Director for Toxicology at the Food and Drug Administration in Washington, D.C., USA.

She developed what she calls "Target Therapy", directed to specific negative intracellular changes in tumors and in cancer. This extensive work resulted in the development of nutrient support measures and therapies in many illnesses including Autoimmune Diseases and cancer.

PRODUCT- http://stemtide.com/products/default.html